Picture of Transgene SA logo

TNG — Transgene SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Transgene Anticipates Significant Progress From Immunotherapy Pipeline In 2024

March 27 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE ANTICIPATES SIGNIFICANT PROGRESS FROM
IMMUNOTHERAPY
PIPELINE IN 2024
    * EXTENDS FINANCIAL VISIBILITY UNTIL Q4 2025

Source text for Workspace:  ID:nGNE6dCmqf 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Transgene SA

See all news